Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionPanagora Asset Management Inc
Latest Disclosed Ownership151,449 shares
Latest Disclosed Value $ 19,951,891
Panagora Asset Management Inc ownership in NBIX / Neurocrine Biosciences, Inc.

On May 14, 2026 - Panagora Asset Management Inc filed a 13F-HR form disclosing ownership of 151,449 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $19,951,891 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Neurocrine Biosciences, Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 151,449 151,449 19,952 0.0747
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -1,559 -100.00 0 -100.00
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,559 1,559 219 0.0009
2025-02-13 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -7,257 -100.00 0 -100.00
2024-11-13 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,257 -389 -5.09 836 -20.53 0.0040
2024-07-29 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 7,646 -259,951 -97.14 1,053 -97.15 0.0053
2024-05-07 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 267,597 197,249 280.39 36,907 298.17 0.1924
2024-02-08 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 70,348 46,245 191.86 9,269 241.90 0.0518
2023-10-31 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 24,103 8,048 50.13 2,712 79.18 0.0168
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,055 5,290 49.14 1,514 38.93 0.0089
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,765 -204 -1.86 1,090 -16.87 0.0069
2023-02-13 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,969 -2,540 -18.80 1,310 -8.71 0.0086
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,509 0 0.00 1,435 8.96 0.0100
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,509 0 0.00 1,317 4.03 0.0086
2022-05-12 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,509 0 0.00 1,266 9.99 0.0069
2022-02-10 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 13,509 -1,264 -8.56 1,151 -18.77 0.0061
2021-11-10 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,773 -109 -0.73 1,417 -2.14 0.0076
2021-08-11 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 14,882 4,609 44.87 1,448 44.94 0.0078
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 10,273 4,067 65.53 999 67.90 0.0056
2021-02-10 2020-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 6,206 -133 -2.10 595 -2.46 0.0035
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 6,339 6,049 2,085.86 610 1,642.86 0.0038
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 290 58 25.00 35 75.00 0.0002
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 232 232 20 0.0001
2019-11-12 2019-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 0 -900 -100.00 0 -100.00
2019-08-09 2019-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 76 -3.80 0.0003
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 79 23.44 0.0004
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 64 -42.34 0.0003
2018-11-13 2018-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 111 26.14 0.0004
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 88 17.33 0.0003
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 75 7.14 0.0003
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 70 27.27 0.0003
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 55 34.15 0.0002
2017-08-14 2017-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 41 5.13 0.0002
2017-05-15 2017-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 39 11.43 0.0002
2017-02-14 2016-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 35 -23.91 0.0002
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 -29,343 -97.02 46 -96.65 0.0002
2016-08-15 2016-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 30,243 -7,125 -19.07 1,375 -6.97 0.0068
2016-05-16 2016-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 37,368 32,780 714.47 1,478 468.46 0.0073
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 4,588 0 0.00 260 42.08 0.0013
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 4,588 2,971 183.74 183 137.66 0.0010
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 1,617 717 79.67 77 113.89 0.0004
2015-05-15 2015-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 36 80.00 0.0002
2015-02-13 2014-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 20 42.86 0.0001
2014-11-12 2014-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 -1,060 -54.08 14 -51.72 0.0001
2014-08-14 2014-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 1,960 1,060 117.78 29 107.14 0.0001
2014-05-15 2014-03-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 0 0.00 14 75.00 0.0001
2014-02-21 2013-12-31 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 900 -600 -40.00 8 -52.94 0.0000
2013-11-14 2013-09-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 1,500 0 0.00 17 -15.00 0.0001
2013-08-14 2013-06-30 13F NEUROCRINE BIOSCIENCES COMMON 64125C109 1,500 1,500 20 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.